Epidemiology of adverse reactions in anaesthesia in Germany and the Netherlands.
We consider 292 anaphylactoid reactions from the own material (1964-1980) out of two different Departments of anesthesiology to attempt to review the continental epidemiology of this life-threatening adverse drug reaction. We conclude the following: The specialty of this type of adverse reaction is likely to prove a special separating name i.e. "anaphylactoid reaction". The overall frequency can be estimated for 1 : 400-600 in anesthesiology, a preponderance of females may be possible. There is no predictability of the reaction, not even by sophisticated history. But it is possible to avoid the development of severe shock by early diagnosis and immediate full causative therapy. With growing experience in diagnosis and therapy the mortality of anaphylactoid reaction should be irrelevant in the near future.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects; D000707:Anaphylaxis / Q000139:chemically induced / Q000453:epidemiology* / Q000503:physiopathology; D000777:Anesthetics / Q000009:adverse effects*; D005260:Female; D005860:Germany, West; D006636:Histamine Release; D006801:Humans; D008297:Male; D009426:Netherlands; D010952:Plasma Substitutes / Q000009:adverse effects
D000759:Adjuvants, Anesthesia; D000777:Anesthetics; D010952:Plasma Substitutes